Cargando…
Personalized medicine in colorectal cancer
Colorectal cancer (CRC) is a heterogeneous disease with various genetic and epigenetic factors leading to difficulties in response to both the therapy and drug resistance. Moreover, even in tumors with similar histopathological characteristics, different responses and molecular features could be obs...
Autores principales: | Vaseghi Maghvan, Padina, Jeibouei, Shabnam, Akbari, Mohammad Esmael, Niazi, Vahid, Karami, Farshid, Rezvani, Alireza, Ansarinejad, Nafiseh, Abbasinia, Masroor, Sarvari, Gisoo, Zali, Hakimeh, Talaie, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881405/ https://www.ncbi.nlm.nih.gov/pubmed/33585000 |
Ejemplares similares
-
Personalized medicine in breast cancer: pharmacogenomics approaches
por: Jeibouei, Shabnam, et al.
Publicado: (2019) -
Network analysis of common genes related to esophageal, gastric, and colon cancers
por: Vaseghi Maghvan, Padina, et al.
Publicado: (2017) -
Radiobiological effects of wound fluid on breast cancer cell lines and human-derived tumor spheroids in 2D and microfluidic culture
por: Jeibouei, Shabnam, et al.
Publicado: (2022) -
Biological and clinical review of IORT-induced wound fluid in breast cancer patients
por: Jeibouei, Shabnam, et al.
Publicado: (2022) -
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
por: Molavi, Zahra, et al.
Publicado: (2021)